ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 517,68
1,22%
Dow Jones
40 589,34
1,64%
DAX
18 417,55
0,62%
Brent Oil
79,745
0,00%
Bitcoin
68 448,65
0,79%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Bone Biologics Corporation (BBLG)

  7. Bone Biologics Corporation (BBLG) Actualités

BBLG

Bone Biologics (BBLG)

Bone Biologics Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BBLG
DateHeureSourceTitreSymboleSociété
21/06/202414h35GlobeNewswire Inc.Life Science Virtual Investor Forum Presentations Now Available for Online ViewingNASDAQ:BBLGBone Biologics Corporation
06/03/202422h15Business WireBone Biologics Announces Closing of $2.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
05/03/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BBLGBone Biologics Corporation
04/03/202423h21Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BBLGBone Biologics Corporation
04/03/202415h15Business WireBone Biologics Announces Pricing of $2.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
01/03/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
01/03/202414h00Business WireBone Biologics Reports Progress With NB1 Clinical ProgramNASDAQ:BBLGBone Biologics Corporation
26/02/202422h50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
21/02/202423h05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BBLGBone Biologics Corporation
15/02/202400h41Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
30/01/202423h09Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BBLGBone Biologics Corporation
19/01/202423h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
17/01/202423h21Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
11/01/202414h00Business WireBone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of DirectorsNASDAQ:BBLGBone Biologics Corporation
10/01/202423h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
10/01/202414h00Business WireBone Biologics Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:BBLGBone Biologics Corporation
05/01/202423h15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BBLGBone Biologics Corporation
18/12/202314h00Business WireBone Biologics Announces 1-for-8 Reverse Stock SplitNASDAQ:BBLGBone Biologics Corporation
29/11/202318h26Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BBLGBone Biologics Corporation
27/11/202312h10Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BBLGBone Biologics Corporation
20/11/202318h38Business WireBone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BBLGBone Biologics Corporation
20/11/202313h44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BBLGBone Biologics Corporation
20/11/202313h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BBLGBone Biologics Corporation
20/11/202312h50Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:BBLGBone Biologics Corporation
16/11/202322h43Business WireBone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BBLGBone Biologics Corporation
14/11/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BBLGBone Biologics Corporation
09/11/202322h51Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BBLGBone Biologics Corporation
26/09/202314h00Business WireBone Biologics Provides Scientific Update on NB1 Bone Graft DeviceNASDAQ:BBLGBone Biologics Corporation
15/09/202322h48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BBLGBone Biologics Corporation
03/08/202312h25Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BBLGBone Biologics Corporation
 Showing the most relevant articles for your search:NASDAQ:BBLG

Dernières Valeurs Consultées

BIT
P1DEM2
BNP Paribas Issuance
BIT
P1REE9
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés